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Syringocystadenoma papilliferum developing
over hyperkeratosis of the nipple in a
pregnant woman
To the Editor: Syringocystadenoma papilliferum
(SCAP) is usually a solitary lesion that most
commonly occurs on the scalp.1 Rarely, lesions
have been described on the breast.1 It usually
presents at birth or develops in childhood as a
warty crusted papule. Although there is increasing
evidence for apocrine histogenesis, eccrine origin
could also be a possibility as well as derivation from
pluripotent cells.1 In approximately one third of
cases, it is associated with organoid nevus2; it has
also been described in association with nevus
comedonicus.3 Here we report, to the best of our
knowledge, the first case of SCAP developing over
hyperkeratosis of the nipple.
A 27-year-old woman in her thirty-fifth week of
first pregnancy presented with a 5-week history of
enlarging asymptomatic skin lesion on the nipple
of her right breast (Fig 1, A). She had had an
asymptomatic verrucous hyperpigmented plaque
diffusely involving the right nipple for 5 years that
was diagnosed as hyperkeratosis of the nipple
(HNA) based on biopsy findings of hyperkeratosis,
keratotic plugging, acanthosis, papillomatosis, and
a sparse perivascular lymphocytic infiltrate (Fig 1,
B). The HNA was stable until a new 0.5-cm
skin-colored papule developed over the HNA
starting in her thirtieth week of gestation. The
Open access under CC BY-NC-ND license.patient was otherwise healthy. Shave excision of
the newly developed lesion revealed papillary
foci in continuity with the surface squamous
epithelium. These papilla had a bilayered epithe-
lium of inner columnar cells showing decapitation
secretion and outer flattened cells as well as a
fibrovascular core containing abundant plasma
cells (Fig 1, C and D). These findings were
consistent with SCAP.
First described in 1923, HNA is a benign condition
of unknown origin.4,5 It is usually bilateral, affecting
young adult women and occurring as a hyperpig-
mented verrucous lesions on the nipple (17%),
areola (25%), or both (58%).4,5 Although HNA shares
clinical and histopathologic features of epidermal
nevus, it is usually acquired after puberty and is
not associated with systemic disease. In 1938,
Levy-Franckel classified HNA into 3 types. Type 1
is an extension of epidermal nevus. Type 2 is usually
associated with several other dermatoses including
ichthyosis, Darier disease, or lymphoma. Type 3 is
the isolated nevoid variant. Hormonal factors may
contribute to its etiopathogenesis in that lesions
appear or worsen in pregnancy or with hormonal
therapy.5
There are yet no reports of an association of
HNA with SCAP or other tumors. The fact that HNA
shows features of an epidermal nevus and may
theoretically be an extension of epidermal nevus
makes the development of different neoplasms,
including SCAP, within it possible, similar to what
has been reported with nevus sebaceous and nevus
comedonicus. The basic defect producing the
hamartomatous process in epidermal nevi that
may result in immature cells capable of differenti-
ating into follicular and glandular cells and tumors
could also be playing a role in SCAP development
over HNA. This is especially true given that a recent
study demonstrated that SCAP could itself be a
hamartomatous tumor arising from pluripotent
cells.1
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Fig 1. A, Syringocystadenoma papilliferum (arrow) developing over hyperkeratosis of the
right nipple. B, Nevoid hyperkeratosis of the nipple. Orthokeratotic hyperkeratosis, acanthosis,
papillomatosis, and a sparse superficial perivascular lymphocytic infiltrate (Hematoxylin-eosin
stain; original magnification:340). C andD, Syringocystadenoma papilliferum. Papillary foci in
continuity with the surface squamous epithelium. These papilla had a bilayered epithelium of
inner columnar cells showing decapitation secretion and outer flattened cells as well as a
fibrovascular core containing abundant plasma cells. C and D, Hematoxylin-eosin stain;
original magnifications: C, 340; D 3200.
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patient with high-risk melanoma
To the Editor: Ipilimumab is a biologic anticancer
therapy used in the treatment of advanced
melanoma. Ipilimumab’s antitumor effect stems
from CTLA-4 blockade, which results in the non-
specific activation of T cells. Rash is a common sideeffect of ipilimumab, with all-grade rash occurring in
approximately 25% of patients and high-grade rash
in 2.4%.1 Cases of toxic epidermal necrolysis,
Stevens-Johnson syndrome, and DRESS have been
reported after ipilimumab exposure.2,3
We present what, to our knowledge, is the first
reported case of Sweet syndrome associated with
ipilimumab therapy. The patient was a 70-year-old
white woman with a history of stage IIIB nodular
melanoma. Six months before admission, she un-
derwent wide local excision and lymphadenectomy
with no evidence of residual disease. Because of her
high risk for recurrence, she elected to enroll in a
clinical trial for adjuvant chemotherapy and was
randomized to receive infusions of high-dose
ipilimumab (10 mg/kg) every 3 weeks. Nineteen
days after receiving her fourth ipilimumab infusion,
she presented to the hospital with a painful rash
(Fig 1) and fever, with temperature of 38.48C.
Cutaneous examination revealed multiple erythem-
atous and tender papules and nodules on her face
and upper extremities, as well as pseudovesicular
lesions on the lips and oral mucosa. Multiple skin
biopsies showed similar histopathologic features of a
